Search results
Results From The WOW.Com Content Network
[table-of-contents] stripped. It’s been a bad year for eye drops. The U.S. Food and Drug Administration (FDA) has issued yet another eye drop recall—this time focusing on 27 different over-the ...
Brimonidine Tartrate Ophthalmic Solution, 0.15%: A special tool designated for those with glaucoma or ocular hypertension, a small subset of these eye drops are being voluntarily recalled as ...
People who purchased a Systane-brand eye drop package can check to see if it is being recalled by looking at the lot number, expiration date and other details on the packaging. Lot 10101. UPC ...
Metoprolol is a beta blocker, or an antagonist of the β-adrenergic receptors. It is specifically a selective antagonist of the β 1-adrenergic receptor and has no intrinsic sympathomimetic activity. [37] Metoprolol exerts its effects by blocking the action of certain neurotransmitters, specifically adrenaline and noradrenaline.
A drug recall removes a prescription or over-the-counter drug from the market. Drug recalls in the United States are made by the FDA or the creators of the drug when certain criteria are met. When a drug recall is made, the drug is removed from the market and potential legal action can be taken depending on the severity of the drug recall. [1]
Here’s who needs to check their medicine cabinets
This list is not limited to drugs that were ever approved by the FDA. Some of them (lumiracoxib, rimonabant, tolrestat, ximelagatran and ximelidine, for example) were approved to be marketed in Europe but had not yet been approved for marketing in the US, when side effects became clear and their developers pulled them from the market.
The U.S. is on track to issue a record number of recalls this year. USA TODAY's recalls database shows you what products should be tossed.